It is known that non-metastatic breast cancer cells do not express IL-6 and IL-8; our data showed that treatment with IL-1β induced their expressions, through the de-methylation of their promotors (Figure 3A–C,F). This evidence concerns the gene IL6 and breast carcinoma.